• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Against a historic market downturn, Moma Therapeutics raises $150M for precision cancer...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 11, 2022 at 11:22: AM
via Moma Therapeutics, a young biotechnology company trying to develop precision cancer treatments, has raised another $150 million to advance research into a family of proteins it describes as the “laborers of the cell.”

article source
 




Top Bottom
Back
Quote